Otomandibular dysplasia associated with monogenic syndromes

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:156202
Who is this for?
Show terms as
1FDA treatments8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Otomandibular dysplasia associated with monogenic syndromes (Orphanet code 156202) is a grouping of rare genetic conditions characterized by developmental abnormalities affecting the ears (oto-) and the lower jaw (mandibular). These malformations arise during embryonic development of the first and second branchial arches, which give rise to structures of the face, jaw, and ears. Patients typically present with underdevelopment or malformation of the mandible (micrognathia or mandibular hypoplasia), external ear anomalies (microtia, anotia, or preauricular tags), and may have middle or inner ear abnormalities leading to conductive or sensorineural hearing loss. Additional craniofacial features can include facial asymmetry, cleft palate, and temporomandibular joint abnormalities. This category encompasses several monogenic (single-gene) syndromes in which otomandibular dysplasia is a prominent feature, including conditions such as Treacher Collins syndrome, oculoauriculovertebral spectrum disorders with identified genetic causes, and other rare craniofacial syndromes. The specific genes involved vary depending on the underlying syndrome and may include TCOF1, POLR1C, POLR1D, and others involved in neural crest cell development and craniofacial morphogenesis. Management is multidisciplinary and depends on the severity and specific syndrome involved. Treatment typically includes surgical reconstruction of the mandible and external ear, orthodontic interventions, hearing aids or surgical correction for hearing loss, speech therapy, and airway management in cases of severe micrognathia. Early audiological assessment is critical to support language development. Genetic counseling is recommended for affected families to clarify the specific diagnosis, inheritance pattern, and recurrence risk.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

1 available

Sogroya

somapacitan-beco· Novo Nordisk Pharmaceuticals

Growth failure associated with Noonan syndrome (NS)

No actively recruiting trials found for Otomandibular dysplasia associated with monogenic syndromes at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Otomandibular dysplasia associated with monogenic syndromes community →

No specialists are currently listed for Otomandibular dysplasia associated with monogenic syndromes.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Sogroya(somapacitan-beco)Novo Nordisk Pharmaceuticals

Travel Grants

No travel grants are currently matched to Otomandibular dysplasia associated with monogenic syndromes.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Otomandibular dysplasia associated with monogenic syndromesForum →

No community posts yet. Be the first to share your experience with Otomandibular dysplasia associated with monogenic syndromes.

Start the conversation →

Latest news about Otomandibular dysplasia associated with monogenic syndromes

No recent news articles for Otomandibular dysplasia associated with monogenic syndromes.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Otomandibular dysplasia associated with monogenic syndromes

What is Otomandibular dysplasia associated with monogenic syndromes?

Otomandibular dysplasia associated with monogenic syndromes (Orphanet code 156202) is a grouping of rare genetic conditions characterized by developmental abnormalities affecting the ears (oto-) and the lower jaw (mandibular). These malformations arise during embryonic development of the first and second branchial arches, which give rise to structures of the face, jaw, and ears. Patients typically present with underdevelopment or malformation of the mandible (micrognathia or mandibular hypoplasia), external ear anomalies (microtia, anotia, or preauricular tags), and may have middle or inner ea

At what age does Otomandibular dysplasia associated with monogenic syndromes typically begin?

Typical onset of Otomandibular dysplasia associated with monogenic syndromes is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Otomandibular dysplasia associated with monogenic syndromes?

1 patient support program are currently tracked on UniteRare for Otomandibular dysplasia associated with monogenic syndromes. See the treatments and support programs sections for copay assistance, eligibility, and contact details.